Stay updated on Nab-sirolimus in Brain Cancer Clinical Trial

Sign up to get notified when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-sirolimus in Brain Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays a newer ClinicalTrials.gov site revision identifier (v3.5.3 instead of v3.5.2), indicating a minor platform/version update rather than a change to the study record.
    Difference
    0.1%
    Check dated 2026-04-24T16:41:44.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:26:55.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T18:04:43.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. No study content or functionality is altered.
    Difference
    0.1%
    Check dated 2026-03-11T15:49:42.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:47:42.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page adds a government funding/status notice and updates to revision v3.4.1, while removing the previous v3.4.0 revision.
    Difference
    0.4%
    Check dated 2026-02-04T00:42:01.000Z thumbnail image

Stay in the know with updates to Nab-sirolimus in Brain Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.